Introduction {#sec1}
============

Modification of the cellular surface with natural or synthetic polymers allows for new opportunities in tissue regeneration and biomedical engineering. As such, control of the cellular microenvironment has become an important tool for controlling cell growth, cell--cell interactions, cytokine expression, stem cell differentiation, and extracellular assembly. The patterning and chemical modification of the surfaces,^[@ref1]−[@ref3]^ the expansion into three-dimensional (3D) by using biomimetic or natural hydrogels,^[@ref4]−[@ref6]^ or layer-by-layer (LbL) assemblies onto the cells are the focus of the current research.^[@ref7]−[@ref11]^ Generally, substrates are bound to the cell membrane via covalent conjugation, hydrogen bonding, and electrostatic, dipole--dipole, or hydrophobic interactions. When mimicking the natural interaction of materials with cells, three key events need to be considered: (1) the composition of the material, (2) cell--membrane interactions, and (3) the composition of the cell membrane itself.

The membrane bilayer is a physical barrier that defines the frontier of the cells and segregates the interior into distinct compartments with specialized functions. The amphiphilic nature of the membrane leads to a negatively charged outer surface and a hydrophobic core inside the membrane, which serves as an anchor for membrane and transmembrane proteins. Consequently, cells have the ability to bind substrates via integrin binding, electrostatic interactions, hydrogen bonds, or hydrophobic interactions. Moreover, the membrane contains a variety of compounds and proteins that are crucial for cellular function. One of the most abundant molecules in the membrane is cholesterol, which is found inside the membrane due to its hydrophobicity. Cholesterol is responsible for membrane integrity and cell signaling and accounts for up to 20% of the membrane's mass.^[@ref12]^ Cholesterol, among the many lipid constituents of mammalian cell membranes, is a key regulator of membrane fluidity and contributes to the formation of caveolae, and in maintaining caveolae microdomain.^[@ref13],[@ref14]^ Caveolae are specialized domains of the plasma membrane that are found in most cell types.^[@ref15]^ However, they are more abundant in cells like adipocytes, endothelial cells, fibroblasts, and muscle cells.^[@ref16]^ In addition to the influence of membrane fluidity, cholesterol is important for cell structure and function, it is essential in locomotion and serves as a metabolic precursor for several signaling molecules, including oxysterols,^[@ref17]^ steroids,^[@ref18]^ and bile acids.^[@ref14],[@ref19],[@ref20]^

The majority of substrates or hydrogels focus on integrin binding sites, in particular the RGD binding site, to generate cell binding, or infiltration. Synthetic materials with covalently bound RGD residues nevertheless struggle to meet the results of native extracellular matrix (ECM) protein materials.^[@ref21]^ Other research for the fabrication of 3D-tissue constructs has focused on cell sheet engineering,^[@ref22]^ magnetic liposomes,^[@ref23]^ cell beads,^[@ref24]^ and cells containing gel layers.^[@ref25]−[@ref27]^ In particular, the creation of cell type specific and target tissue specific nano- and microdomains using biological interactions, such as avidin--biotin,^[@ref28]−[@ref31]^ antibody--antigen,^[@ref32],[@ref33]^ lectin--polysaccharides,^[@ref34],[@ref35]^ or ECM proteins like fibronectin, collagen and/or gelatin,^[@ref25],[@ref26],[@ref36]−[@ref40]^ has shown promising results in "hierarchical-cell manipulation" in vitro.^[@ref9],[@ref10],[@ref36],[@ref39]^

In this approach, a cell coating based on hydrophobic interactions with the cell membrane is presented. To reduce the batch-to-batch and other host-specific variations of organism-derived proteins, an ECM analogue elastin-like recombinamer (ELR) is used as a model protein for the tissue-inductive coating. The main objective is the creation of a well-distributed initial layer of protein on the cells. As such, the potential of hydrophobic groups as intramembranous anchors for cellular coatings is determined. Cholesteryl side groups were selected as hydrophobic anchors to mimic the intramembranous situation and to facilitate the mobility and distribution of the proteins in the membrane. For better interaction of the cholesterol material with the membrane, caveolin-rich cell types like human umbilical vein endothelium-derived cells (HUVEC) and human aortic smooth muscle cells (HASMC), which are involved in lipid uptake from sanguine fluid and in processes such as stenosis, were selected.^[@ref16]^

Results {#sec2}
=======

Modification of the ELR with the BCN linker, fluorophore, and CTA groups was successfully performed by a two-step synthesis ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). The number of incorporations was followed by NMR spectroscopy, and the results are displayed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} (complete NMR spectra can be found in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)).

![Synthetic Route of Cholesteryl Modification of ELR at Free Lysine's Through BCN-Mediated Cycloaddition](ao-2019-00548t_0009){#sch1}

###### Overview of NMR Signals and the Related Conversion of Functional Groups[a](#t1fn1){ref-type="table-fn"}

                    **P1** (normalized) 0.6--1.0   **P2** 2.85--2.95   \#BCN
  ----------------- ------------------------------ ------------------- -------
  VKV               1335                                                
  VKV--BCN (CTA0)   1335                           21.01               10.5

           **P1** 0.6--1.0 ppm   **P3** 5.30--5.45 ppm   \#CTA   **P4** 10.1--10.3
  -------- --------------------- ----------------------- ------- -------------------
  CTA0\*   1335                                          0       0.91
  CTA1     1335                  1.19                    1.19     
  CTA1\*   1335                  0.95                    0.95    1.59
  CTA3     1335                  3.03                    3.03     
  CTA3\*   1335                  3.33                    3.33    1.54
  CTA5     1335                  4.03                    4.03     
  CTA5\*   1335                  6.09                    6.09    1.10

**P1** serves as internal reference, representing −CH~3~ and −CH~2~-- protons of amino acid residues (G, E, L, K, M, P, S, V); **P2** represents H~2~C--O(C=O)O-- of the BCN linker; **P3** represents C=C--H proton of the cholesteryl residue; **P4** is an isolated signal from the Eterneon fluorophore (structure not known). Complete spectra are provided as [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_002.pdf).

The hydrodynamic radii of ELR^CTA^ in a phosphate-buffered saline (PBS) was determined by dynamic light scattering (DLS). However, as the multimodality of the sample above the lower critical solution temperature (LCST) did not allow for size-average comparison, the volume intensities were plotted ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Moreover, volume intensities allow for small particle detection in a complex precipitating sample. All of the samples have similar size at 4 °C, ranging between 3 and 7 nm, which corresponds to 2--10 ELR molecules according to the size--mass calibration. An additional population of 2 nm particles, which might correspond to unimers is observed in CTA5. Above the LCST, CTA0 agglomerates into larger structures and precipitates from solution, starting with 30 nm particles and larger micrometer-sized populations in the initial stage of precipitation. Upon cholesteryl addition, a significant shift toward smaller particles is observed above the LCST in the volume intensities, as well confirmed by a left shift of the correlation function ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Addition of more CTA groups leads to a reduction in the number of larger particles, which is most prominent in CTA5, similar to conditions below the LCST. The cloud point of the samples was determined as the derivative of the absorbance versus temperature profile of ELR^CTA^. A significant increase in turbidity and related absorbance was only observed in CTA0, which was already drastically reduced in CTA1, with a transition temperature (*T*~t~) of 23.9 and 26.0 °C and a maximum absorbance of 1.6 and 0.3, respectively. No changes in absorbance were observed for CTA3 and CTA5 in the temperature range 5--40 °C ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), which is in accordance with the decrease in the number of larger agglomerates observed by DLS.

![Volume Intensities of cholesteryl ELRs in PBS at different temperatures. Graphs show an overlay of three individual measurements. Black arrows mark the size shift of distributions.](ao-2019-00548t_0001){#fig1}

![Correlation function of CTA0, 1, and 5 at 4 and 37 °C. Most prominent is the left shift of CTA1 and 5 at 37 °C, indicating the presence of smaller aggregates/particles (CTA3 was removed for better visibility).](ao-2019-00548t_0002){#fig2}

![Cloud point determination of ELRs. The cholesteryl-modified ELRs show markedly reduced to no absorbance above the LCST of CTA0.](ao-2019-00548t_0003){#fig3}

The different substrates were tested for their effect on cell proliferation over 7 days using the alamarBlue assay at the concentrations of 375 and 750 nM. The values were normalized to nonconditioned cells grown on tissue-culture polystyrene (TCPS) for better visibility. The HUVECs showed no significant differences in proliferation under all conditions ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A), whereas for HASMCs, treatment with cholesteryl ELRs (ELR^CTA^) at 750 nM led to a decreased proliferation for CTA0 and CTA1 at day 1 and for all conditioned samples at day 3 and 7, which became more significant with time ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B). Moreover, the cytostatic effect is more pronounced in CTA0 and CTA1 on days 1 and 7. The lower concentration (375 nM) had no negative effect on proliferation.

![Metabolic activity of cells incubated with ELRs and ELR--CTA at 375 and 750 nM: (A) HUVEC cells and (B) HASMC. *P* values refer to cells cultured on TCPS (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001).](ao-2019-00548t_0004){#fig4}

All subsequent incubation studies were performed at concentrations of 375 nM as proliferation of both cell lines was unaffected at this concentration. The cell--ELR interaction was quantified by FACS, with the number of fluorescent events increasing from CTA0 to CTA5, as indicated by a right shift in the dot plots from 10 to 80% (HUVEC), or from 20 to 85% (HASMC), fluorescent cells ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A--E; HASMC dot plots are provided as [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)). The HASMC cells interact with the material to a higher extent at low cholesteryl contents, increasing from 20 to 60% from CTA0 to CTA3, whereas the coating efficiency of these ELRs remains below 30% with the HUVEC cells ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}F).

![Forward scatter intensity (FS INT) vs fluorescence (FL3 INT) of the HUVEC cells treated with CTA samples, obtained by flow cytometry. (A) Untreated HUVEC cells; (B) HUVEC cells treated with CTA0, (C) HUVEC cells treated with CTA1, (D) HUVEC cells treated with CTA3, (E) HUVEC cells treated with CTA5, and (F) fluorescence fraction of HUVEC and HASMC cells. See the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi) for the HASMC dot plots. *P* values refer to the cells treated with CTA0 (\**P* \< 0.05; \*\**P* \< 0.01).](ao-2019-00548t_0005){#fig5}

Confocal images of trypsinized cells after incubation revealed a change in the ELR distribution on the cell membrane that is dependent on the cholesteryl content, ranging from more agglomerated micron-sized particles to finely dispersed sub-micron dots, with this being found for both cell lines ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). Additionally, a Z-scan was performed for the sample with dispersed fluorescence to determine the fluorescence distribution. The localized presence of ELR^CTA^ in the cell center (first five layers), followed by depletion of fluorescence in the center (subsequent layers), indicates binding of ELR to the membrane ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). Live cell imaging further revealed an increased aggregation of bound ELRs in HASMC (CTA0 and CTA1) and an increased dispersion of ELR in both HUVEC and HASMC (CTA5) (results are shown in the right part of [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}, and in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)).

![Confocal images of HUVEC (A) and HASMCs (B) after incubation with CTAx samples. From left to right: texas red (displayed color was changed to magenta for better visibility of small particles), phase, and merge. Top to bottom: CTA0, CTA1, CTA3, and CTA5. The scale bars represent 7.5 μm.](ao-2019-00548t_0006){#fig6}

![Z-Slicing of HUVEC cell with CTA5. Slices are from top to bottom starting from the top left (z04) to the bottom right image (z19). ELR fluorescence in the top image covers most of the cell surface, whereas in the lower slices, the ELR is more concentrated at the perimeter of the cell, thus indicating that the ELR is not incorporated into the cells. The scale bars represent 7.5 μm, slicing depth is 0.4 μm.](ao-2019-00548t_0007){#fig7}

![Schematic interaction of cholesteryl ELR with the cell membrane. Upon incubation, the cholesteryl-ELR adsorbs to the membrane. Over time, the ELR either agglomerates on the cell membrane or is further distributed on the membrane. Top right: ELR--CTA0\* incubated with HASMC, ELR--CTA0\* sticks to the membrane and agglomerated due to ELR--ELR contacts. Bottom right: ELR--CTA5\* incubation, cells maintain mobility and ELR--CTA5\* is distributed in small dots throughout the membrane. The left images indicates *t*~0~ after incubation, the right images *t* = 6 h. Scale bar equals 50 μm.](ao-2019-00548t_0008){#fig8}

Discussion {#sec3}
==========

Several studies concerning polymer--membrane interactions and internalization have been published in recent years.^[@ref26],[@ref41]^ Indeed, it is well-documented that biophysical properties such as net charge, hydrophobicity, and protein-driven cell--ligand (integrin binding) interactions influence the interaction of polymers, proteins, or peptides with model membranes and biological cells.^[@ref42]^ Most polymer modifications have focussed on the introduction of a positive charge to foster electrostatic interactions with the membrane (polycations),^[@ref26]^ or on the insertion of integrin-binding domains (like RGD).^[@ref41]^ Since integrin-binding amino acid sequences frequently contain charged residues, both these approaches increase the net charge and hydrophilicity of the material. The basis for this study was an antagonistic approach that makes use of a set of carefully designed ELRs of varying hydrophobicities to trigger membrane--substrate interactions. For the introduction of hydrophobic moieties, a strategy of postexpressional modification with cholesteryl groups was used to keep other peptide properties, such as peptide charge and charge distribution, unchanged. Cholesteryl groups were selected as cell-anchor moieties due to the abundance and importance of cholesterol in the cell structure, function, and locomotion; furthermore, the ability of membranes to stabilize cholesteryl groups is thought to assist the coordination of hydrophobic ELRs to the membrane. The main objective was to generate a defined cellular coating of a recombinant protein that allows for total sequence control and less host or batch-to-batch variation as a substitute for the existing coatings such as alginate,^[@ref25]^ polyelectrolytes,^[@ref26]^ collagens, and fibronectin.^[@ref38]−[@ref40]^

An in vitro cell-binding assay was used to quantify cell--membrane interactions. Thus, HUVEC and HASMC were incubated with molecular probes of varying cholesteryl concentrations ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). At 37 °C, ELR^CTA0^ and ELR^CTA^ are above their LCST of 23.9 and 26 °C, respectively ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}); therefore, precipitation and hydrophobic ELR--ELR interactions are more favored, and agglomeration occurs. This agglomeration can be prevented upon the introduction of cholesteryl side chains, which hamper the aggregation and lead to the disappearance of the LCST transition. Although more hydrophobic, the agglomeration of ELR^CTA^ was not observed. For a better understanding of LCST disappearance in CTA samples, the CD spectra were recorded at 37 °C, which showed a slight decrease of random coil signal at 197 nm upon cholesteryl addition, indicating an increased order toward β-turn^[@ref43]^ and α helical structures,^[@ref44]^ which is consistent with studies on cholesteryl-modified polylysine.^[@ref45]^ Nevertheless, besides slightly augmented order, overall spectra were quite similar (data shown in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)) and give no explanation on diminished precipitation. Consequently, we assume that cholesteryl is destabilizing micelles in ionic solutions such as PBS, thereby forcing the ELRs to form monomers, which, given their size, are nonabsorbent even above the LCST. Furthermore, the probes with higher amounts of cholesterol showed a significant increase in ELR binding to the cell membrane as hydrophobic interactions with the membrane lead to a better distribution of the material in the membrane. It is believed that the abundance of cholesterol in the cell membrane and its hydrophobic nature further foster the cell--ELR^CTA^ interaction. The hypothesized mechanism of cellular ELR association relates to the cholesterol content ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}). Thus, in the absence of cholesteryl groups, the ELR agglomerates over time to form micron-sized particles as a result of hydrophobic and electrostatic interactions ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}; further images and video are shown in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)), whereas increasing numbers of cholesteryl groups lead to a weakening of the ELR^CTA^--ELR^CTA^ interaction and to an increased ELR--membrane interaction under physiological conditions, thus resulting in the distribution of the ELR in the cell membrane.Live cell imaging of all cell types supported the hypothesis whereby the larger agglomerates, which bind to the cell membranes, are still mobile and tend to bind to each other upon contact. High cholesteryl contents led to ELRs being very finely dispersed throughout the membrane. The marked mobility of the ELR^CTA^s in the cell membrane (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)) indicates that the interaction with the membrane does not reduce cell mobility. Moreover, the HUVEC cells did not interact with ELRs CTA \< 3 and the agglomerated ELR, with these ELRs binding to the well-plate and their organization remaining unchanged over time. In contrast, in the HASMC cells, the ELR fragments adhere to the membrane and are moved around by the cells, thus resulting in growth of the agglomerates as a result of an increased probability for ELR--ELR contacts. The increased membrane affinity for cholesteryl groups overcomes the ELR--ELR interaction, thus resulting in more dispersed particles in solution as well as on the membrane and increasing the number of fluorescent-positive cells. The HASMCs are less selective than HUVECs and actively bind low-cholesteryl ELRs, with the amount of bound ELR per cell appearing to be higher, as characterized by a second population of right-shifted cells with a fluorescent intensity of 10^2^--10^3^. However, the tendency of ELR^CTA^ to be dispersed was observed in both cell lines. The distribution of the ELRs is shown in detail in the confocal images, which show how the ELR agglomerates of CTA0 or CTA1 are bound to the membrane as micrometer-sized particles, changing with increasing cholesterol content into a myriad of submicron-sized small ELR dots within the membrane. Confocal imaging also supports the fact that most of the ELR remains in close proximity to the membrane; nonetheless, incorporation into the cells cannot be fully excluded. In light of the data obtained from flow cytometry, the incorporation of ELRs into the membrane, or the association of ELR with the membranes, does not negatively affect cell proliferation, as would be indicated by an increased amount of cell debris in ungated dot plots ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi)).

Although elastin-like proteins (ELPs, also referred to as ELRs) with a similar constitution to CTA0 presented herein have been reported to be tunable in terms of membrane interactions due to changes in temperature, thereby resulting in changes of hydrophobicity and the good interaction of CTA0 (*T* \> *T*~t~) with HASMC cells, it should be noted that much lower concentrations were used in our work.^[@ref41]^ Simnick et al. further showed that integrin receptor-like interactions could be used to further increase cell--ligand interactions.^[@ref41]^ The augmented affinity to cell membranes with cholesteryl anchors was further reported with modified hyaluronan,^[@ref46]^ or DNA.^[@ref47]^ The differences in CTA groups on cellular uptake might be explained by the involvement of cells in lipid uptake. Cholesterol can interact with other proteins via both covalent^[@ref48]^ and noncovalent mechanisms,^[@ref49],[@ref50]^ thereby regulating protein stability, localization,^[@ref51]^ and activity.^[@ref20]^ Cholesterol accumulation is one of the primary events in atherosclerosis within specific and specialized cell types such as SMCs, where it results in uncontrolled uptake, whereas endothelial cells maintain tight cholesterol homeostasis,^[@ref52]^ which might explain the selectivity of HUVECs for high ELR^CTA^ concentrations. Furthermore, it has been shown that, in contrast to SMCs, endothelial cells do not undergo the foam cell phenotypic change in atherosclerotic plaques, a change characterized by the unrestricted accumulation of cellular cholesterol,^[@ref53]^ which would explain the cytostatis of HASMC at 750 nM ELR^CTA^. It should be noted that CTA0 and CTA1 have a more cytostatic effect on HASMCs, which, in turn, means that cholesteryl groups improve the cytocompatibility of CTA0. Although the interaction of CTA0 and CTA1 with cells is possibly mediated by electrostatic interactions with the remaining free lysines of the ELR, this interaction is not strong enough to disrupt the hydrophobic ELR--ELR interaction above the LCST, thus resulting in the growth of bound aggregates over time.

Conclusions {#sec4}
===========

The general mechanisms of cell--substrate binding are based on integrin--substrate binding, or polycation LbL coatings, and phagocytosis of positively charged polyplexes. However, this work provides an additional cue by using hydrophobic entities as mediators of cell--substrate interactions. In this work, cholesterol groups are used as a cellular anchor to enhance the membrane substrate interaction of an elastin-like recombinamer (ELR). The resulting materials showed enhanced cellular recognition and matrix distribution, in line with the number of CTA groups incorporated.

To the best of our knowledge, hydrophobic moieties that function as cellular membrane anchors for proteins have not yet been investigated to date. Since no negative proliferative effect on cells was observed in selected cell types at concentrations resulting in \>60% of fluorescently labeled cells, the present system may lead to a better understanding of hydrophobic membrane--substrate interactions and the development of novel hydrophobicity-driven cell coatings that could potentially replace current coatings. Furthermore, these novel materials and their versatility in terms of protein sequence have high potential as cellular markers, drug carriers, or hydrophobic cell-binding domains. The cell specificity also allows for further optimization of the process by varying concentrations, incubation times and the number of cholesteryl groups. This system may also help to understand the mechanisms by which vascular endothelial cells maintain tight cholesterol homeostasis and may shed light on the mechanisms of cellular sterol transport, or high-density lipoprotein-dependent RCT. Future studies will focus on ELR--cholesteryl systems with fewer ELR--ELR attractions at 37 °C to extract the driving force of membrane distribution and the related contribution of cholesteryl groups, or the ELRs themselves.

Materials and Methods {#sec5}
=====================

Synthesis {#sec5.1}
---------

The genetic construction of the ELRs used in this work, which were bioproduced and supplied by Technical Proteins Nanobiotechnology, S.L. (TPNBT, S.L., Spain), was performed according to Rodríguez-Cabello et al., 2012.^[@ref54]^ In brief, the ELR sequence (MESLLP VG VPGVG \[VPGKG(VPGVG)~5~\]~23~ VPGKG VPGVG VPGVG VPGVG VPGV) was genetically designed and produced in *Escherichia coli*. Purification was carried out using alternating precipitation and resolvation cycles, induced by response of the LCST of the ELR upon heating and cooling (inverse temperature cycling), followed by dialysis (12 000 MWCO---Medicell Membranes Ltd., Liverpool) and sterile filtration (0.22 μm; Nalgene). The sterile product was freeze-dried and stored at −20 °C until further use.

Chemical Functionalization of ELR VKV with BCN *N*-Hydroxysuccinimide Ester \[**1**\] {#sec5.2}
-------------------------------------------------------------------------------------

BCN moieties were introduced by amidation of the free lysines (K) present in the ELR backbone, using the *N*-hydroxysuccinimide (NHS) esters of the active compound (1*R*,8*S*,9*S*)-bicyclo\[6.1.0\]non-4-*yn*-9-ylmethyl *N*-succinimidyl carbonate (BCN--NHS; Synaffix, Netherlands). The ELR (25 μmol; 1 equiv) was dissolved in dimethylformamide (DMF) and, after complete dissolution, a solution of 2 mL BCN--NHS (250 μmol; 10 equiv) in DMF was added dropwise under nitrogen atmosphere. The reaction mixture was then stirred overnight at room temperature. The pure product **1** was obtained as a white fibrous tissue after precipitation in diethyl ether, followed by washing in acetone, dialysis (12 000 MWCO---Medicell Membranes Ltd., Liverpool), and freeze-drying. The degree of modification was determined by NMR (referencing **P1** and **P2**) and MALDI-TOF. ^1^H NMR (400 MHz, D~2~O, δ in ppm): **P1** 0.6--1.0 (m, CH~3~), **P2** 2.85--2.95 (t, 2H, −CH~2~--NH--(C=O)--O−). The NMR spectra were recorded using an Agilent 400 MHz NMR spectrometer operating at a resonance frequency of 399.95 MHz for ^1^H. The spectra were recorded in D~2~O (20 mg/mL) by performing 500 scans. The degree of conversion was estimated by ^1^H NMR, quantifying the isolated α-(C(=O)NH--alkyl) signals of the introduced functionalities. The conversion of lysine groups with BCN was limited to 60% due to solubility issues.

Covalent Binding of Fluorescent Probe and Cholesterol Moieties \[**2**\] {#sec5.3}
------------------------------------------------------------------------

The active ELRs were treated with either triethyleneglycol-cholesterol azide (CTA; Sigma) and/or Eterneon azide (Jena Bioscience). ELRs containing 0, 1, 3, or 5 cholesteryl groups were generated (CTA0--5).

First, the ELR--BCN **1** (20 μmol; 1 equiv) was dissolved in DMF and the azide CTA (0, 1, 3, 5 equiv) in DMF was added dropwise under nitrogen then stirred overnight at room temperature. The pure product **2** was obtained as a white fibrous tissue after precipitation in diethyl ether, followed by washing in acetone, dialysis (12 000 MWCO---Medicell Membranes Ltd., Liverpool), and freeze-drying. The degree of modification was determined by NMR (referencing **P1** and **P3**) and MALDI-TOF. ^1^H NMR (400 MHz, D~2~O, δ in ppm): **P1** 0.6--1.0 (m, CH~3~), **P3** 5.30--5.45 (s, 1H, C--CH=C). All samples obtained were further modified for detection by insertion of a fluorophore (CTA0--5\*). Thus, a solution of CTA0--5 (10 μmol; 1 equiv) in DMF was treated with Eterneon azide (1 μmol; 0.1 equiv) under nitrogen in the dark for 24 h and purified as product **1**. Due to the unknown structure of the commercial compound, insertion of the fluorophore was confirmed by fluorescence spectroscopy and by comparison of the ^1^H NMR spectra of the adduct and product. A new isolated singlet at 10.1--10.3 ppm (**P4**) was observed ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).

###### Degree of Modification Calculated from Mass Analysis[a](#t2fn1){ref-type="table-fn"}

         *M*~w~ (MALDI-TOF)   calculated BCN/CTA groups
  ------ -------------------- ---------------------------
  VKV    60 977                
  CTA0   63 505               BCN: 13,146
  CTA1   64 446               CTA: 1,49
  CTA3   66 019               CTA: 3,98
  CTA5   67 096               CTA: 5,69

Complete spectra are provided as the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_002.pdf).

Spectrophotometric Cloud Point Determination {#sec5.4}
--------------------------------------------

The absorbance of the ELR solutions was recorded using a Cary Series UV--vis spectrophotometer (Agilent Technologies). The ELR solution was prepared in PBS (125 μM) and recorded using the CaryWinUV Thermal Application (version 4.20(468)) over a temperature interval ranging from 5 to 40 °C at a heating rate of 1 °C/min.

Dynamic Light Scattering {#sec5.5}
------------------------

The average size distribution of the modified ELRs was determined by DLS using a Zetasizer Nano (Malvern Instruments, Worcestershire, U.K.) at 4 or 37 °C, configured with a 173° scattering angle and equipped with a HeNe laser (633 nm) with an output power of 10 mW. Solutions (125 μM) of the nonfluorescent ELR--CTA modifications were dissolved in cold PBS and filtered (0.45 μm poly(vinylidene fluoride) syringe filter) prior to analysis. The samples were incubated for 10 min at the specified temperature. Each sample was measured in triplicate due to LCST-related polydispersity of ELRs volume intensities of samples are displayed.

Cell Culture {#sec5.6}
------------

Dulbecco's modified Eagle medium, Medium 231, and smooth muscle growth supplement (SGMS) were purchased from Thermo Fisher Scientific, fetal bovine serum, penicillin streptomycin (P/S) solution, trypsin--ethylenediaminetetraacetic acid, Dulbecco's phosphate-buffered saline (DPBS), and alamarBlue were supplied by Invitrogen. Human umbilical vein endothelial cells (HUVECs, cc-2517) and endothelial growth medium (EGM-2) were purchased from Lonza (Lonza, Europe). Human aortic smooth muscle cells (HASMC, ref CRL-1999) were purchased from the American Type Culture Collection (ATCC).

HUVECs were cultured in EGM-2 supplemented with 1% P/S and HASMCs were cultured in Medium 231 supplemented with SGMS and 1% P/S. The cells were incubated at 37 °C under 5% CO~2~, and their medium was replaced every 2 days.

The relative number of metabolically active cells was evaluated using the alamarBlue assay according to the manufacturer's guidelines. The culture was incubated in 10% alamarBlue solution for 3 h at 37 °C and under a 5% CO~2~ atmosphere. The cells were cultured in triplicate with medium containing 375 nM, or 750 nM of the nonfluorescent substrates, for 1, 3, and 7 days, respectively. The data sets were normalized to the same cell type and at the same time point grown on TCPS. A two-way analysis of variance multiple comparison was performed using the Holm--Šídák multiple comparison test. \*\*\*\**P* \< 0.0001; \*\*\**P* ≤ 0.001; \*\**P* ≤ 0.01; \**P* \< 0.05.

FACS and Confocal Microscopy {#sec5.7}
----------------------------

A total of 250 000 cultured cells per condition were incubated for 24 h, followed by incubation in serum-free media containing ELR^CTA^ (375 nM) for 18 h. After incubation, the cells were washed several times with cold DPBS to remove unbound ELRs, then trypsinized, and resuspended in cold DPBS.

Flow cytometry analysis was performed to assess the amount of ELR^CTA^-positive cells. A total of 50 000 events were detected in the cytometer (Gallios flow cytometer, Beckman-Coulter). Quantification was performed using Kaluza software v1.2 (Beckman-Coulter); for better quantification, the fluorescent channel was presented on a logical scale with a linear region from −2 to 15.

The samples used for FACS quantification were visualized using a Leica SP5 confocal microscope (Leica Microsystems, Heidelberg) with a 63× lens. For better contrast in the merged image, the red channel was displayed in magenta. Z-Slicing depth on selected cells was set to 0.4 μm.

The cells prepared for FACS were cultured in 96-well plates to track ELR^CTA^ in living cells. Thus, 3000 cells incubated with ELR^CTA^ were imaged for 18 h at 0.56 mfps. Bright-field and fluorescence microscopy were performed using a NIKON Eclipse Ti fluorescence microscope equipped with a digital camera system (Digital sight DS-2MBWc) (Nikon, Japan).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b00548](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b00548).Result of hydrophobic and electrostatic interactions ([AVI](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_001.avi))NMR spectra, live cell imaging of HUVEC and HASMCs over a period of 18 h, FS vs SS plots for all conditions, FS vs fluorescence plots for HASMCs ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00548/suppl_file/ao9b00548_si_002.pdf))
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